Drug Profile
Research programme: mitochondrial permeability transition pore inhibitors - MGI GP
Alternative Names: GPI-19410Latest Information Update: 20 Feb 2008
Price :
$50
*
At a glance
- Originator MGI GP
- Class Small molecules
- Mechanism of Action Mitochondrial permeability transition pore inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Neurodegenerative disorders; Reperfusion injury
Most Recent Events
- 31 Dec 2007 Discontinued - Preclinical for Neurodegenerative disorders in USA (unspecified route)
- 31 Dec 2007 Discontinued - Preclinical for Reperfusion injury in USA (unspecified route)